Adverse Experience Reporting. During the term of the Agreement, each party shall notify the other immediately of any information concerning any serious or unexpected side effect, injury, toxicity or sensitivity reaction, or any unexpected incidence, and the severity thereof, associated with the clinical uses, studies, investigations, tests and marketing of the Product. For purposes of this Article 13, "
Appears in 2 contracts
Samples: License and Collaboration Agreement (Trinity Medical Group Inc), License and Collaboration Agreement (Trinity Medical Group Inc)
Adverse Experience Reporting. During the term of the Agreement, each party Party shall notify the other immediately of any information (howsoever obtained and from whatever source) concerning any serious or unexpected side effect, injury, toxicity or sensitivity reaction, or any unexpected incidence, and the severity thereof, associated with the clinical uses, studies, investigations, tests and marketing of the Producta Product or Material. For purposes of this Article 13, "
Appears in 2 contracts
Samples: Option and License Agreement (Corixa Corp), Option and License Agreement (Corixa Corp)
Adverse Experience Reporting. During the term of the Agreement, each party Party shall notify the other immediately of any information (howsoever obtained and from whatever source) concerning any serious or unexpected side effect, injury, toxicity or sensitivity reaction, or any unexpected incidence, and the severity thereof, associated with the clinical uses, studies, investigations, tests and marketing of the Producta PRODUCTS. For purposes of this Article 13Section 8.5, "
Appears in 2 contracts
Samples: Patent and Know How License Agreement (Drugabuse Sciences Inc), Patent and Know How License Agreement (Drugabuse Sciences Inc)
Adverse Experience Reporting. During the term of the Agreement, each party Party shall notify the other immediately of any information (howsoever obtained and from whatever source) concerning any serious or unexpected side effect, injury, toxicity or sensitivity reaction, or any unexpected incidence, and the severity thereof, associated with the clinical uses, studies, investigations, tests and marketing of PRODUCTS and, to the Productextent feasible, any other product containing VECTOR (hereinafter, a "PRODUCT"), or VECTOR. For purposes of this Article 1315, "
Appears in 1 contract
Adverse Experience Reporting. During the term of the Agreement, each party Party shall notify the other immediately of any information (howsoever obtained and from whatever source) concerning any serious or unexpected side effect, injury, toxicity or sensitivity reaction, or any unexpected incidence, and the severity thereof, associated with the clinical uses, studies, investigations, tests and marketing of PRODUCTS and, to the Productextent feasible, any other product containing COMPOUND (hereinafter, a "PRODUCT"), or COMPOUND. For purposes of this Article 1315, "
Appears in 1 contract
Adverse Experience Reporting. During the term of the Agreement, each party Party shall notify the other immediately of any information (howsoever obtained and from whatever source) concerning any serious or unexpected side effect, injury, toxicity or sensitivity reaction, or any unexpected incidence, and the severity thereof, associated with the clinical uses, studies, investigations, tests and marketing of the Producta PRODUCTS. For purposes of this Article 138.6., "
Appears in 1 contract
Samples: Collaboration and Option Agreement (Cistron Biotechnology Inc)